FI68359C - Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning - Google Patents

Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning Download PDF

Info

Publication number
FI68359C
FI68359C FI791565A FI791565A FI68359C FI 68359 C FI68359 C FI 68359C FI 791565 A FI791565 A FI 791565A FI 791565 A FI791565 A FI 791565A FI 68359 C FI68359 C FI 68359C
Authority
FI
Finland
Prior art keywords
solution
buffer
prostacyclin
active compound
sodium
Prior art date
Application number
FI791565A
Other languages
English (en)
Finnish (fi)
Other versions
FI68359B (fi
FI791565A (fi
Inventor
Ian Seymour Watts
Peter Hugh Marsden
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI791565A publication Critical patent/FI791565A/fi
Publication of FI68359B publication Critical patent/FI68359B/fi
Application granted granted Critical
Publication of FI68359C publication Critical patent/FI68359C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI791565A 1978-05-17 1979-05-16 Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning FI68359C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2017578 1978-05-17
GB2017578 1978-05-17

Publications (3)

Publication Number Publication Date
FI791565A FI791565A (fi) 1979-11-18
FI68359B FI68359B (fi) 1985-05-31
FI68359C true FI68359C (fi) 1985-09-10

Family

ID=10141640

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791565A FI68359C (fi) 1978-05-17 1979-05-16 Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning

Country Status (28)

Country Link
US (1) US4335139A (it)
EP (1) EP0005768B1 (it)
JP (1) JPS54163809A (it)
KR (1) KR830000527B1 (it)
AT (2) AT365926B (it)
AU (1) AU525695B2 (it)
BE (1) BE876296A (it)
CA (1) CA1141661A (it)
CH (1) CH641044A5 (it)
CS (1) CS214798B2 (it)
DE (2) DE2920020A1 (it)
DK (1) DK156004C (it)
ES (1) ES480597A1 (it)
FI (1) FI68359C (it)
FR (1) FR2425856A1 (it)
GR (1) GR68452B (it)
HU (1) HU182746B (it)
IL (1) IL57298A (it)
IT (1) IT1116840B (it)
LU (1) LU81272A1 (it)
MC (1) MC1265A1 (it)
NL (1) NL7903871A (it)
NZ (1) NZ190462A (it)
PH (1) PH15850A (it)
PL (1) PL134004B1 (it)
SE (1) SE450930B (it)
SU (1) SU978715A3 (it)
ZA (1) ZA787353B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010002A1 (de) * 1980-03-15 1981-10-01 Hoechst Ag, 6000 Frankfurt Prostaglandine enthaltende pharmazeutische zubereitung
PT90888B (pt) * 1988-06-17 1994-12-30 Wellcome Found Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
GB8814438D0 (en) * 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
JP3421330B2 (ja) * 2000-11-02 2003-06-30 持田製薬株式会社 ビダラビン注射用乾燥製剤
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
US7491263B2 (en) 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly
ES2323286T3 (es) * 2005-06-29 2009-07-10 Verisfield (Uk) Ltd. Composiciones farmaceuticas de risperidona en disolucion acuosa.
CA2641393C (en) 2006-02-03 2014-12-16 Scidose Llc Novel epoprostenol formulation and method of making thereof
CN101827612A (zh) 2007-09-07 2010-09-08 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
HU231031B1 (hu) 2016-03-23 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Megnövelt stabilitású epoprostenol nátrium és eljárás előállítására
DE202024100435U1 (de) 2023-02-14 2024-02-22 Tomasz Dąbrowski Zaunfeld zum Aufbau einer Reitbande

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4036954A (en) 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
GB1504437A (en) 1974-03-08 1978-03-22 Dunlop Ltd Rubberplastics composites
DE2515001C2 (de) * 1975-04-04 1986-10-02 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandin enthaltende gefriergetrocknete Pulver
US3997587A (en) 1975-06-26 1976-12-14 Syntex (U.S.A.) Inc. D1- and 8R-9-fluoro-prostadienoic acid derivatives
US4005133A (en) 1975-10-14 1977-01-25 The Upjohn Company PGF2.sub.α, L-Arginine salt
FR2351112A1 (fr) * 1975-10-21 1977-12-09 Wellcome Found Derive de prostaglandine et medicament contenant ce derive
US4062964A (en) 1975-12-03 1977-12-13 Ciba-Geigy Corporation Antifertility-combinations
GB1583961A (en) * 1976-05-11 1981-02-04 Wellcome Found Prostacyclin and derivatives thereof
CH643458A5 (en) * 1977-05-20 1984-06-15 Wellcome Found Pharmaceutical composition and a process for its production

Also Published As

Publication number Publication date
DE2920020A1 (de) 1979-11-29
MC1265A1 (fr) 1980-03-28
ATE4411T1 (de) 1983-08-15
FI68359B (fi) 1985-05-31
ATA363479A (de) 1981-07-15
EP0005768B1 (en) 1983-08-10
NZ190462A (en) 1982-05-31
DK156004B (da) 1989-06-12
BE876296A (fr) 1979-11-16
IL57298A (en) 1983-09-30
SE450930B (sv) 1987-08-17
SU978715A3 (ru) 1982-11-30
HU182746B (en) 1984-03-28
FR2425856B1 (it) 1982-06-25
DE2966046D1 (en) 1983-09-15
GR68452B (it) 1981-12-30
SE7904284L (sv) 1979-11-18
CH641044A5 (de) 1984-02-15
AT365926B (de) 1982-02-25
US4335139A (en) 1982-06-15
FI791565A (fi) 1979-11-18
AU4704279A (en) 1979-11-22
KR830000527B1 (ko) 1983-03-12
IT1116840B (it) 1986-02-10
CS214798B2 (en) 1982-05-28
JPS54163809A (en) 1979-12-26
LU81272A1 (fr) 1979-12-07
FR2425856A1 (fr) 1979-12-14
IL57298A0 (en) 1979-09-30
IT7949064A0 (it) 1979-05-16
NL7903871A (nl) 1979-11-20
DK201879A (da) 1979-11-18
EP0005768A1 (en) 1979-12-12
DE2920020C2 (it) 1988-09-01
AU525695B2 (en) 1982-11-25
PL134004B1 (en) 1985-07-31
PL215627A1 (it) 1981-08-07
ZA787353B (en) 1980-08-27
JPS6358810B2 (it) 1988-11-17
DK156004C (da) 1989-11-06
ES480597A1 (es) 1980-08-16
CA1141661A (en) 1983-02-22
PH15850A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
KR100514963B1 (ko) 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물
FI68359C (fi) Foerfarande foer framstaellning av en stabil prostacyklinkomposition foer terapeutiskt anvaendning
US4310543A (en) Prostaglandin compositions
NO171828B (no) Fremgangsmaate for fremstilling av et stabilisert farmasoeytisk preparat inneholdende en granulocyttkolonistimulerende faktor
KR100349772B1 (ko) 결정성무수물미코페놀레이트모페틸및그의정맥제형
JPS61165322A (ja) スパガリン類の注射用凍結乾燥製剤
KR100389726B1 (ko) 안정한 과립구 콜로니-자극 인자 함유 제제
FI83476B (fi) Foerfarande foer framstaellning av en beredning av 7 -difluorometyltioacetamido-7 -metoxi-3-/1-(2 -hydroxialkyl)-1h-tetrazol-5-yl/tiometyl-1-detia-1-oxa-3-cefem-4 -karboxisyra.
JP3726255B2 (ja) 安定な凍結乾燥済みチオテパ組成物
FI90824B (fi) Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi
AU5409201A (en) Solution of N-(O-(p-pivaloyloxy benzene sulfonylamino) benzoyl)glycine monosodium salt tetra-hydrate and drug product thereof
EP0278243B1 (en) Medical preparation comprising aspoxicillin, a method for its preparation, and the use of such a preparation for the manufacture of a medicament
IE48231B1 (en) Pharmaceutical formulations containing prostaglandin compounds
JPH03264531A (ja) セファロスポリン凍結乾燥製剤
JP2020533318A (ja) ドセタキセル結合体の医薬組成物及び調製方法
US4338325A (en) PGI2 Pharmacologically acceptable salts
JPS6137728A (ja) セフタジダイムの改良医薬製剤
KR101314500B1 (ko) 안정성이 개선된 옥사세펨 제제 및 그 제조방법
EP0402477B1 (en) Use of isocarbacyclins for preventing or treating organ diseases
KR900000747B1 (ko) 비경구용 세파만돌 나페이트 제제의 제조방법
CN115737571A (zh) 一种喷他佐辛制剂及其制备方法和用途
GB2167302A (en) Stable lyophilized antibacterial preparations

Legal Events

Date Code Title Description
MA Patent expired
MA Patent expired

Owner name: THE WELLCOME FOUNDATION LIMITED